Artificial Bone Market Five Years Forecast Skeleton AlloSource, Johnson & Johnson, NuVasive, and Smith & Nephew

HA is the main inorganic component of nature bones, accounting for about 60% of the bone composition. Porous HA ceramics have remarkable usage in biomedical applications, including bone tissue regeneration, cell proliferation, and drug delivery. In bone tissue engineering, it is applied as a filling material for bone defects and augmentation, artificial bone graft material, and prosthesis revision surgery. Moreover, significant research is being conducted to use innovative biomaterials such as carbon nanomaterials in bone tissue engineering. Carbon-based prostheses are promising materials, which mimic the natural function of bones, offering relevant mechanical strength.

A variety of synthetic polymers, natural polymers, and bioceramics are being used to develop artificial bones and are being investigated for their physiochemical role in vivo, which are currently in clinical trial stages. Furthermore, carbon-based bone materials, such as carbon nanotubes and graphene, have been widely investigated as potential solutions to several biomedical problems. Electrical and mechanical properties of carbon nanotubes (CNTs) are important key properties, which can used for bone tissue engineering. Among this, electrical properties of carbon nanotubes used to stimulate the cell towards osteogenic differentiation, and mechanical properties can be used to mimic the mechanical strength of the bone.

Get FREE Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1899

Rising incidence of trauma and accidents across the globe, in turn, is increasing the prevalence of bone damage, which is thus expected to boosting the growth of the artificial bone market. For instance, according to the Centers for Disease Control and Prevention (CDC), around 2.5 million people were hospitalized in the U.S. in 2014, due to accident injuries, indicating high risk of bone damage. This in turn, offers lucrative opportunity to boost artificial bone market over the forecast period (2018 – 2026). Moreover, the National Trauma Institute in 2014, revealed that economic burden due to trauma cases increased to US$ 671 billion, including healthcare costs and lost productivity costs.

Artificial Bone Market – Drivers

Increasing number of trauma cases is increasing the visits of patients in trauma centres. According to the National Ambulatory Medical Care Survey (NAMCS), in 2010, around 63 million visits to the orthopedic surgery department were recorded and around 3.5 million visits for fractures in the emergency departments in the U.S. Additionally, among the 6.5 million bone fracture or defect cases, around 887,679 were hospitalized. Various other factors such as presence of key operating players and collaborative partnerships among the players are responsible for positioning North America as the largest market for artificial bone market.

Artificial Bone Market – Competitor

Some of the key players operating in the artificial bone market are Baxter International Inc., Medtronic plc, Stryker Corporation, Orthofix International N.V., AlloSource, Inc., Johnson & Johnson (DePuy Synthes), NuVasive, Inc., and Smith & Nephew plc.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1899

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.